Literature DB >> 24981456

Diabetes: Glycaemia and insulin after acute myocardial infarction.

Paresh Dandona1, Ajay Chaudhuri1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24981456     DOI： 10.1038/nrendo.2014.101

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  10 in total

1.  Intensive glucose control in hyperglycemic patients with acute coronary syndromes: still smoke, but no fire....

Authors:  Paresh Dandona; William E Boden
Journal:  JAMA Intern Med       Date:  2013-11-11       Impact factor: 21.873

2.  Intensive glucose regulation in hyperglycemic acute coronary syndrome: results of the randomized BIOMarker study to identify the acute risk of a coronary syndrome-2 (BIOMArCS-2) glucose trial.

Authors:  Maarten de Mulder; Victor A Umans; Jan H Cornel; Friso M van der Zant; Frank Stam; Rohit M Oemrawsingh; K Martijn Akkerhuis; Eric Boersma
Journal:  JAMA Intern Med       Date:  2013-11-11       Impact factor: 21.873

3.  Effects of glucose-insulin-potassium infusion on ST-elevation myocardial infarction in patients treated with thrombolytic therapy.

Authors:  Gordana Krljanac; Zorana Vasiljević; Mina Radovanović; Goran Stanković; Natasa Milić; Branislav Stefanović; Jasminka Kostić; Predrag Mitrović; Nebojsa Radovanović; Mirjana Dragović; Jelena Marinković; Ana Karadzić
Journal:  Am J Cardiol       Date:  2005-08-24       Impact factor: 2.778

4.  The Hyperglycemia: Intensive Insulin Infusion in Infarction (HI-5) study: a randomized controlled trial of insulin infusion therapy for myocardial infarction.

Authors:  N Wah Cheung; Vincent W Wong; Mark McLean
Journal:  Diabetes Care       Date:  2006-04       Impact factor: 19.112

5.  Out-of-hospital administration of intravenous glucose-insulin-potassium in patients with suspected acute coronary syndromes: the IMMEDIATE randomized controlled trial.

Authors:  Harry P Selker; Joni R Beshansky; Patricia R Sheehan; Joseph M Massaro; John L Griffith; Ralph B D'Agostino; Robin Ruthazer; James M Atkins; Assaad J Sayah; Michael K Levy; Michael E Richards; Tom P Aufderheide; Darren A Braude; Ronald G Pirrallo; Delanor D Doyle; Ralph J Frascone; Donald J Kosiak; James M Leaming; Carin M Van Gelder; Gert-Paul Walter; Marvin A Wayne; Robert H Woolard; Lionel H Opie; Charles E Rackley; Carl S Apstein; James E Udelson
Journal:  JAMA       Date:  2012-03-27       Impact factor: 56.272

6.  Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial.

Authors:  Shamir R Mehta; Salim Yusuf; Rafael Díaz; Jun Zhu; Prem Pais; Denis Xavier; Ernesto Paolasso; Rashid Ahmed; Changchun Xie; Khawar Kazmi; Javed Tai; Andrés Orlandini; Janice Pogue; Lisheng Liu
Journal:  JAMA       Date:  2005-01-26       Impact factor: 56.272

7.  Glucose normalization and outcomes in patients with acute myocardial infarction.

Authors:  Mikhail Kosiborod; Silvio E Inzucchi; Harlan M Krumholz; Frederick A Masoudi; Abhinav Goyal; Lan Xiao; Philip G Jones; Suzanne Fiske; John A Spertus
Journal:  Arch Intern Med       Date:  2009-03-09

8.  Tight glycemic control reduces heart inflammation and remodeling during acute myocardial infarction in hyperglycemic patients.

Authors:  Raffaele Marfella; Clara Di Filippo; Michele Portoghese; Franca Ferraraccio; Maria Rosaria Rizzo; Mario Siniscalchi; Emilio Musacchio; Michele D'Amico; Francesco Rossi; Giuseppe Paolisso
Journal:  J Am Coll Cardiol       Date:  2009-04-21       Impact factor: 24.094

9.  Anti-inflammatory and profibrinolytic effect of insulin in acute ST-segment-elevation myocardial infarction.

Authors:  Ajay Chaudhuri; David Janicke; Michael F Wilson; Devjit Tripathy; Rajesh Garg; Arindam Bandyopadhyay; Janeen Calieri; Debbie Hoffmeyer; Tufail Syed; Husam Ghanim; Ahmad Aljada; Paresh Dandona
Journal:  Circulation       Date:  2004-02-02       Impact factor: 29.690

10.  Intensified insulin-based glycaemic control after myocardial infarction: mortality during 20 year follow-up of the randomised Diabetes Mellitus Insulin Glucose Infusion in Acute Myocardial Infarction (DIGAMI 1) trial.

Authors:  Viveca Ritsinger; Klas Malmberg; Anton Mårtensson; Lars Rydén; Hans Wedel; Anna Norhammar
Journal:  Lancet Diabetes Endocrinol       Date:  2014-05-13       Impact factor: 32.069
  10 in total
  1 in total

1.  An Elevated Glycemic Gap is Associated with Adverse Outcomes in Diabetic Patients with Acute Myocardial Infarction.

Authors:  Wen-I Liao; Chin-Sheng Lin; Chien-Hsing Lee; Ya-Chieh Wu; Wei-Chou Chang; Chin-Wang Hsu; Jen-Chun Wang; Shih-Hung Tsai
Journal:  Sci Rep       Date:  2016-06-13       Impact factor: 4.379
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.